Home > Practice > Current Affairs > May - 2024 > May 23, 2024
1. Which pharmaceutical company has received approval from the US Food and Drug Administration (USFDA) to market generic medication for treating asthma?
Zydus Lifesciences has obtained final approval from the USFDA to market Theophylline extended-release tablets (300 mg and 450 mg), a generic medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This approval enables Zydus to introduce this medication to the US market, expanding its pharmaceutical offerings.